Evidence map›Paper›PMID 36643214›Full record

ArticleIntegrative medicine (Encinitas, Calif.)2022

Patient-Specific Dietary Therapy to Treat Chronic Diseases.

Owen Miller, Jeffrey Wong

Open access · greenAbstract readCase Reports
In one paragraph

Article in Integrative medicine (Encinitas, Calif.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Owen Miller
Jeffrey Wong

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although unconventional, for many years naturopathic physicians have theorized that patient-specific dietary intolerances are a significant cause of chronic disease. This is in addition to common health limiting dietary factors, such as excess calories or insufficient nutrients. Over the past 36 years of clinical practice, our doctors have developed a unique patient-specific dietary evaluation and treatment strategy aimed at preventing, mitigating, and even resolving chronic disease. We call this procedure the Advanced Universal Dietary Intolerance Test (AUDIT). The goal of this dietary therapy is to improve health and decrease risk by identifying and eliminating a patient's unique food intolerances. The AUDIT is similar to the standard E-RD, which for many decades has been considered by the naturopathic profession to be the "gold standard" for identifying dietary intolerances. Although the standard technique has a history of being helpful, its shortcomings regarding efficiency and accuracy significantly limit its utility. The AUDIT is an attempt to resolve these issues. Contrary to the common technique (E-RD), which depends largely on subjective patient improvement upon elimination and an exacerbation upon reintroduction, the AUDIT employs common objective markers. These include weight, lipid panel, blood sugar, and a metabolic panel to validate the results. Unlike the many weeks required by the common technique to make a distinction of intolerance, the AUDIT tracks rise in water weight (i.e., systemic edema) that occurs after a five-day elimination phase. Twelve hours after reintroducing a test food, the initial observation is made of a patient-specific intolerance reaction. The second association is observed in the improvement of laboratory markers after 5 weeks of the AUDIT, defining a reduction in disease risk. This outcome study demonstrates that AUDIT has the potential to prevent and treat some of the common chronic diseases seen in primary care. Though not presented in this literature, patients who followed the AUDIT strategy routinely achieved a long-term, sustainable improvement in their chronic disease, or even a resolution.

Identifiers

PMID36643214
PMCPMC9831135
OpenAlexW4316687606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.